Drug Type ASO |
Synonyms AIMers |
Target |
Mechanism A1AT modulators(Alpha-1-antiproteinase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alpha 1-Antitrypsin Deficiency | Preclinical | SG | 07 Mar 2022 |